3 posts in this category
Latest updates on Indiana, Florida, and federal GLP-1 compounding laws and what the changes could mean for patient access in 2026.
We’re working hard to keep things updated but give us some grace to work with providers who are potentially changing their offerings around tirzepatide.
We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?
